Tiziana Life Sciences – Appointment of Director February 5, 2021 – Posted in: Tiziana Life Sciences (TILS)

5th February, 2021 APPOINTMENT OF DIRECTOR Tiziana Life Sciences plc (NASDAQ: TLSA / LSE: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, today announces the appointment of Dr Thomas Adams, Ph.D. as an executive director. Dr Adams will assume the position of Head of Drug Development with immediate effect and his executive role will be to manage and oversee all matters relating to the Company’s pre-clinical and clinical…

Continue reading